About this ipamorelin digest

What this project is

Legit Ipamorelin is an independent editorial project that publishes summaries of the peer-reviewed research literature on ipamorelin. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The project exists because the gap between what is claimed for ipamorelin and what the studies actually establish is unusually wide. Marketing leans on a clean mechanism and a few short rodent experiments; the controlled human record is one pharmacokinetic study and one trial that failed. A vetted digest puts both in plain view, with every figure carried back to its source.

What "legit" means here

The word in the name is a posture toward the evidence, not a verdict on any seller and not a claim that this site offers anything legitimate to buy. "Legit" means we grade the quality of the studies, distinguish ipamorelin's own data from class-level evidence borrowed from its chemical relatives, and flag plainly where the popular combination protocols outrun what has been tested. We do not endorse vendors, we do not imply any product's legitimacy, and we treat community claims as unverified anecdote unless a study supports them.

The ornamented, period-formal tone is editorial character, not authority. It does not make the thin evidence thicker. Where the data stops, we say so.

How we handle sources

Every quantitative claim on this site maps to a numbered citation on the references page, with a DOI or PubMed link. We describe what was administered, to which species, at what dose, by what route — never a human dose recommendation. When a finding comes from a peptide in ipamorelin's family rather than ipamorelin itself, the text says which compound was studied. The aim is a digest a careful reader can audit line by line, and one a careful machine can read just as easily.